Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
03 Sep 2026, 16:40:17 UTC
Prior SEC filing
13 Apr 2026
Next SEC filing
03 Nov 2026
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Douglas Barry, Attorney-in-Fact
Filing notes and source

Key filing fact

Michael R. Megna filed Form 4 for Kiniksa Pharmaceuticals International, plc (KNSA) on 03 Sep 2026.

Key facts

  • This page summarizes Michael R. Megna's Form 4 filing for Kiniksa Pharmaceuticals International, plc (KNSA).
  • 13 reported transactions and 6 derivative rows are listed below.
  • Accepted by SEC: 03 Sep 2026, 16:40.

Change

  • Previous filing in this sequence was filed on 13 Apr 2026.
  • Current net transaction value: -$369,380.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001464583 Primary reporting owner

Megna Michael R

Relationship
CHIEF ACCOUNTING OFFICER
Address
C/O KINIKSA PHARMACEUTICALS INT'L, 105 PICCADILLY, SECOND FLOOR, LONDON, UNITED KINGDOM
Signature
/s/ Douglas Barry, Attorney-in-Fact
Signature date
03 Sep 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

KNSA transaction

Class A Ordinary Share

Award

Transaction value
Shares
+279
Change %
+1%
Price
$33.50*
Shares after
27,697
Date
15 Jul 2026
Ownership
Direct
Footnotes
F1
KNSA transaction

Class A Ordinary Share

Options Exercise

Transaction value
Shares
+3,932
Change %
+14%
Price
Shares after
31,629
Date
01 Sep 2026
Ownership
Direct
Footnotes
F2
KNSA transaction

Class A Ordinary Share

Options Exercise

Transaction value
Shares
+2,558
Change %
+8.1%
Price
Shares after
34,187
Date
01 Sep 2026
Ownership
Direct
Footnotes
F2
KNSA transaction

Class A Ordinary Share

Options Exercise

Transaction value
Shares
+2,362
Change %
+6.9%
Price
Shares after
36,549
Date
01 Sep 2026
Ownership
Direct
Footnotes
F2
KNSA transaction

Class A Ordinary Share

Options Exercise

Transaction value
Shares
+2,644
Change %
+7.2%
Price
Shares after
39,193
Date
01 Sep 2026
Ownership
Direct
Footnotes
F2
KNSA transaction

Class A Ordinary Share

Tax liability

Transaction value
Shares
-5,531
Change %
-14%
Price
$79.28*
Shares after
33,662
Date
01 Sep 2026
Ownership
Direct
KNSA transaction

Class A Ordinary Share

Sale

Transaction value
-$369,380
Shares
-4,600
Change %
-14%
Price
$80.30
Shares after
29,062
Date
03 Sep 2026
Ownership
Direct
Footnotes
F3

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

KNSA transaction Derivative

Restricted Share Unit

Award

Transaction value
Shares
+3,650
Change %
Price
$0.000000*
Shares after
3,650
Date
01 Sep 2026
Ownership
Direct
Underlying class
Class A Ordinary Share
Underlying amount
3,650
Exercise price
Footnotes
F2, F4
KNSA transaction Derivative

Share Option

Award

Transaction value
Shares
+14,600
Change %
Price
$0.000000*
Shares after
14,600
Date
01 Sep 2026
Ownership
Direct
Underlying class
Class A Ordinary Share
Underlying amount
14,600
Exercise price
$79.28
Footnotes
F5
KNSA transaction Derivative

Restricted Share Unit

Options Exercise

Transaction value
Shares
-2,644
Change %
-25%
Price
$0.000000*
Shares after
7,931
Date
01 Sep 2026
Ownership
Direct
Underlying class
Class A Ordinary Share
Underlying amount
2,644
Exercise price
Footnotes
F2, F6
KNSA transaction Derivative

Restricted Share Unit

Options Exercise

Transaction value
Shares
-2,362
Change %
-33%
Price
$0.000000*
Shares after
4,725
Date
01 Sep 2026
Ownership
Direct
Underlying class
Class A Ordinary Share
Underlying amount
2,362
Exercise price
Footnotes
F2, F7
KNSA transaction Derivative

Restricted Share Unit

Options Exercise

Transaction value
Shares
-2,558
Change %
-50%
Price
$0.000000*
Shares after
2,557
Date
01 Sep 2026
Ownership
Direct
Underlying class
Class A Ordinary Share
Underlying amount
2,558
Exercise price
Footnotes
F2, F8
KNSA transaction Derivative

Restricted Share Unit

Options Exercise

Transaction value
Shares
-3,932
Change %
-100%
Price
$0.000000*
Shares after
0
Date
01 Sep 2026
Ownership
Direct
Underlying class
Class A Ordinary Share
Underlying amount
3,932
Exercise price
Footnotes
F2, F9
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Rule 10b5-1 trading plan

These transactions were reported as open-market trades under a Rule 10b5-1 plan. The plan lets an insider set trading instructions in advance, which can reduce the risk of trading while in possession of material nonpublic information.

Original filing language: transaction made pursuant to a contract, instruction, or written plan intended to satisfy Rule 10b5-1(c).

Explanation of responses 9 footnotes

Footnote F1

The reporting person is voluntarily reporting the acquisition of these shares pursuant to the Issuer's 2018 Employee Share Purchase Plan for the purchase period of January 16, 2026 to July 15, 2026. The acquisition of these shares was exempt pursuant to Rule 16b-3(e).

Footnote F2

Each Restricted Share Unit (RSU) represents a contingent right to receive one Class A Ordinary Share of the Issuer.

Footnote F3

This transaction was effected pursuant to a 10b5-1 plan executed by the reporting person on May 24, 2025.

Footnote F4

The RSUs vest over a four-year period, with 25% of the RSUs vesting on each yearly anniversary of the date of grant, September 1, 2026.

Footnote F5

The option vests and becomes exercisable as to 25% of the total grant on the first anniversary of the vesting commencement date and vests in 36 equal monthly installments thereafter. The vesting commencement date is September 1, 2026.

Footnote F6

The RSUs vest over a four-year period, with 25% of the RSUs vesting on each yearly anniversary of the date of grant, September 1, 2025.

Footnote F7

The RSUs vest over a four-year period, with 25% of the RSUs vesting on each yearly anniversary of the grant date, September 1, 2024.

Footnote F8

The RSUs vest over a four-year period, with 25% of the RSUs vesting on each yearly anniversary of the date of grant, September 1, 2023.

Footnote F9

The RSUs vest over a four-year period, with 25% of the RSUs vesting on each yearly anniversary of the date of grant, September 1, 2022.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .